Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1976-03-05
1977-07-05
Rizzo, Nicholas S.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
260243C, A61K 31545
Patent
active
040340899
ABSTRACT:
The antibacterial agent 7-[D-.alpha.-amino-.alpha.-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5- ylthiomethyl)-3-cephem-4-carboxylic acid, which is a zwitterion, is both purified and converted to a form highly suitable for use in aqueous suspensions by converting it to the crystalline 7-[D-.alpha.-amino-.alpha.-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5- ylthiomethyl)-3-cephem-4-carboxylic acid 1,2-propylene glycolate, said propylene glycolate containing 1.0 - 1.6 moles of 1,2-propylene glycol per mole of cephalosporin zwitterion.
REFERENCES:
patent: 3867380 (1975-02-01), Dunn et al.
The Merck Index Eighth Edition pp. 876-877(1968).
Granatek Alphonse Peter
Kaplan Murray Arthur
Bristol-Myers Company
Morse David M.
Rizzo Nicholas S.
LandOfFree
Aqueous suspensions of 7-[D-.alpha.-amino-.alpha.-(p-hydroxyphen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aqueous suspensions of 7-[D-.alpha.-amino-.alpha.-(p-hydroxyphen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aqueous suspensions of 7-[D-.alpha.-amino-.alpha.-(p-hydroxyphen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-578233